openPR Logo
Press release

In Vivo Toxicology Market 2020-2025: Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc, JANVIER LABS, Thermo Fisher Scientific and more.

03-29-2021 06:08 AM CET | Health & Medicine

Press release from: ReportsnReports

In Vivo Toxicology Market 2020-2025: Charles River

According to Market Study Report, In Vivo Toxicology Market provides a comprehensive analysis of the In Vivo Toxicology Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1346555

The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period.

Top Key Players Profiled in the In Vivo Toxicology Market:
• Charles River Laboratories (US)
• The Jackson Laboratory (US)
• Envigo (US)
• Taconic Biosciences Inc. (US)
• JANVIER LABS (France)
• Thermo Fisher Scientific (US)
• Danaher Corporation (US)
• Waters Corporation (US)
• Agilent Technologies (US)
• Shimadzu Corporation (Japan)
• Bruker Corporation (US)
• PerkinElmer (US).
• Merck KGaA (Germany)
• GE Healthcare (US)
• Bio-Rad Laboratories (US)
• genOway (France)
• Cyagen Biosciences (US)
• GVK BIO (India)
• PolyGene (Switzerland)
• Crown Biosciences (US)
• TransCure bioServices (France)
• Ozgene Pty Ltd. (Australia)
• Harbour BioMed (US)

Access full report and get 20% Discount @ https://www.reportsnreports.com/purchase.aspx?name=1346555

The in vivo toxicology market is categorized into instruments and consumables. The consumables segment is further categorized into animal models and reagents & kits. Animal models is sub segmented into mice, rat and other animals. The consumables segment accounted for the largest share of the in vivo toxicology market in 2019.

“By toxicity endpoint, the immunotoxicity segment accounted for the largest share of the in vivo toxicology market.”
The global in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental & reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation). In 2019, the immunotoxicity segment accounted for the largest share of the global in vivo toxicology market, followed by the systemic toxicity segment.

“By test type, chronic test type segment accounted for the largest share of the in vivo toxicology market”
The global in vivo toxicology market is segmented into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. In 2019, the chronic test type segment held the largest share of the market, followed by sub-chronic test type.

“By End user, Academic and Research Institutes accounted for the largest share of the in vivo toxicology market”
The global in vivo toxicology market has been broadly segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). The academic and research institutes segment accounted for the largest share of the in vivo toxicology market in 2019.

“Asia Pacific: The fastest-growing region in the in vivo toxicology market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region.

Breakdown of primary participants’ profile:
• By Respondent– Supply Side- 80%, Demand Side-20%
• By Designation— Executives- 25%, CXOs- 20%, Managers - 55%
• By Region— North America - 50%, Europe - 20%, APAC – 20%, RoW- 10%

Reason to access this report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies.

#Customization Service of the Report:
ReportsnReports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Ask Question @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1346555

Corporate Headquarters
Tower B5, office 101
Magarpatta SEZ,
Hadapsar, Pune-411013, India

About Us:-
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vivo Toxicology Market 2020-2025: Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc, JANVIER LABS, Thermo Fisher Scientific and more. here

News-ID: 2262931 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Vivo

Vivo City: Redefining Luxury Living in Nelamangala
Nelamangala's [Bangalore] transformation is fuelled by its strategic location and enhanced connectivity. Simultaneously, the relative affordability of land compared to Bengaluru's core districts has spurred significant residential development. This influx of infrastructure and population has created a dynamic real estate market ripe for innovative projects. SJR Vivo City is positioned to capitalize on this growth, offering a distinct vision of luxury living that caters to the aspirations of modern homebuyers.
In Vivo Toxicology Market
The global in vivo toxicology market is anticipated to grow at a significant CAGR of over 4% during the forecast period. The increasing investments for R&D are one of the major driving factors for the in vivo toxicology market. The researchers are investing in huge amounts of drugs in the initial levels to reduce the risks of its failure during the later expensive levels of trials. This reduces time consumption
In Vivo Imaging Systems Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the In Vivo Imaging Systems industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The In Vivo Imaging Systems market survey report has been prepared by conducting market research in a systematic manner. Moreover, the In Vivo Imaging Systems
In Vivo Imaging Systems Market 2022 | Detailed Report
The In Vivo Imaging Systems research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the
IntraSense – world's smallest in-vivo pressure sensor for catheter
AMSYS GmbH & Co. KG, November 2021 - With the IntraSense, AMSYS presents the smallest in-vivo pressure sensor for integration into catheters with only 1 French diameter. Measuring only 750 μm × 220 μm × 75 μm, the sensor already has a highly flexible, fully protected cable connected for ease of use. The sensor is designed to operate in air and saline fluids such as blood, cerebro-spinal fluid or urine.
Ex-Vivo Organ Perfusion Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Ex-Vivo Organ Perfusion Market is projected to grow at a CAGR value of around 7.2% during the forecast period [2021 to 2026]. Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Ex-Vivo Organ Perfusion Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/ex-vivo-organ-perfusion-market-3460 By Perfusion Technology (Hypothermic Perfusion Technology and Normothermic